Loading...
XKRX
322510
Market cap71mUSD
Jul 10, Last price  
4,680.00KRW
1D
11.30%
1Q
-31.98%
IPO
-46.76%
Name

JLK Inc

Chart & Performance

D1W1MN
XKRX:322510 chart
P/E
P/S
35.81
EPS
Div Yield, %
Shrs. gr., 5y
11.39%
Rev. gr., 5y
-5.75%
Revenues
3.34b
+133.94%
56,487,0604,489,991,4903,786,050,4303,415,330,7202,488,983,7501,427,510,0003,339,486,000
Net income
-13.40b
L-0.37%
-10,608,590,390-7,637,096,090-7,574,087,080-9,011,647,520-7,323,283,580-13,453,718,000-13,404,133,000
CFO
-12.34b
L+12.86%
-6,422,835,820-4,116,260,230-5,979,952,000-7,899,937,340-6,379,349,160-10,935,979,000-12,342,197,502

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

JLK, Inc., a South Korean enterprise, provides artificial intelligence-powered solutions to aid in patient diagnostics. The company's offerings span both AI medical and AI security applications. Its advanced AI platform delivers real-time, on-site services, integrating effortlessly with hospital infrastructure to fulfill the diagnostic needs of healthcare professionals. JLK's medical segment addresses a diverse array of conditions, supporting their management, treatment, and overall service. This includes a significant focus on neurological disorders like ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease. Furthermore, the company extends its capabilities to lung diseases, coronary artery disease, prostate cancer, and digital pathology. Formerly known as JLK INSPECTION Co.,Ltd., JLK, Inc. is headquartered in Cheongju, South Korea.
IPO date
Dec 11, 2019
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT